Leading the way with innovative technology, launching a new era of wound repair in Australia

Mr. Stewart Hemsley

Chief Executive Officer

Stewart has been self-employed across a number of industry sectors for most of his working life and a few years ago established what is today, Surgical BioFix Ltd.  He has a long history of involvement in health and education related facilities having served in an honorary capacity on a number of boards of management and advisory committees in those disciplines, as well as commercial involvement in property development.


He has been responsible for the design and construction of the Surgical BioFix Ltd facility in Brisbane after having negotiated the IP Licence Agreement regarding the production and distribution of the Surgical BioFix Ltd produced human tissue allograft products into the Australia, New Zealand and South Pacific markets.


He was also responsible for the sourcing and training of staff for the facility.  Stewart has many years of experience in commercial and community group liaison with local, state and federal government and is a Justice of the Peace in Queensland and New South Wales.


A/Prof. Tony Parker, PhD

Chief Scientific Officer

Associate Professor Parker has over 12 years of experience in tissue injury, wounds and tissue engineering research. He holds a PhD in cell biology from Queensland University of Technology (QUT). Prior to joining Surgical BioFix he was the program leader (now deputy) of the Tissue Repair and Translational Physiology (TRTP) Program at the Institute of Health and Biomedical Innovation (IHBI) at QUT.


He also maintains a position as Associate Professor within the School of Biomedical Sciences at QUT where he teaches anatomy, physiology, cell and molecular biology and wound science. A/Prof Parker’s research focuses on musculoskeletal and skin tissue injury and recovery processes. He has published 37 peer reviewed journal articles in the international scientific literature in areas including wound and tissue injury and has trained over 29 research and higher degree students.


He also played a leading role in the establishment of the world class wound fluid analysis capability at QUT. In particular, his team specialises in the utilisation of 3D experimental skin wound models and has developed the workflows required for the biochemical characterisation of wound and tissue fluids.


Dr. Kylie Alcorn, MBBS, FRACP

Medical Director

Dr Kylie Alcorn is an Infectious Disease physician working in South East Queensland Hospitals. Her professional interests include general Infectious Disease, orthopaedic infections and the professional development of doctors. She has held positions including Acting Director of Infectious Disease and Immunology and served on several medical advisory committees in several hospitals in South East Queensland.

After completing undergraduate studies at the Queensland University of Technology (QUT), she completed her medical degree training at the University of Melbourne before returning to the glorious warm weather in Brisbane. She completed her Fellowship in Medicine with specialty training in Infectious Diseases in South East Queensland, and postgraduate observerships in Berlin and Oxford.

She is an active researcher with current projects investigating vaccine development for malaria and antibiotics for diabetic foot infections. Dr Alcorn is committed to life-long learning and is soon to complete a Masters in Tropical Medicine and Public Health from James Cook University.

Dr. Platon Choptiany

Medical Director Designee

Dr Choptiany is originally from Winnipeg, Manitoba, Canada but moved to Brisbane in 2006 where he completed his MBBS at the University of Queensland.  Following this he completed his Fellowship in General and Acute Care Medicine and is currently undertaking Advanced Training in Infectious Diseases. 


He has worked throughout Queensland over the last 10 years including Gold Coast, Rockhampton, Caboolture, Murgon, Cherbourg and Brisbane. 


He is currently undertaking a Masters of Public Health through the University of Queensland and has previously completed a Bachelor of Science and Masters of Science in Physiology at the University of Manitoba. 


Dr. Yee Chng

Quality Manager

Dr Yee Chng has 9 years of experience working in research laboratory environments and operating specialised laboratory equipment. Prior to joining Surgical BioFix, Yee was completing her PhD study within the Tissue Repair and Translational Physiology (TRTP) program at the Institute of Health and Biomedical Innovation (IHBI) at QUT.


Her research focused on the identification and characterisation of urinary proteins following anterior cruciate ligament injury and recovery. During her PhD study, Yee developed an interest in bioinformatics data analysis using R programming and was employed by the TRTP program to mentor and help guide junior PhD students with their data analysis.


She also has over 8 years of teaching experience as a sessional academic for Anatomy and Physiology units within the School of Biomedical Sciences at QUT. Her role was to supervise students during laboratory practical classes and facilitate student understanding of anatomy and physiology. Yee spent a month visiting with StimLabs LLC in Atlanta USA, the developers of Revita, to learn the quality management systems associated with the production of Revita. She is now employed as the Surgical BioFix Quality Manager.

Wound Headshots-34 _cropped.jpg

Dr. Dario Stupar

Production Manager

Dr Dario Stupar has over 10 years of laboratory experience in the field of tissue repair and regeneration. Prior to completing his PhD, he worked as a research assistant in a Brisbane based Biotechnology company developing wound repair technology. He went on to complete a PhD in Biochemistry at the Institute of Health and Biomedical Innovation at the Queensland University of Technology.


His PhD focused on biochemical analysis of samples obtained from patients suffering from chronic leg ulcers. Following his PhD, he worked overseas as a Research Fellow at the Agency for Science, Technology and Research (A*STAR) in Singapore.


His research focused on translating research outcomes to develop novel therapies and devices to enable tissue repair. Dario is currently employed as the Production Manager to oversee all day-to-day operational processes.

Dr. Geoffrey Catton, MBBS, DCH FACNEM

Medical Advisor 

Dr. Catton is a Brisbane based General Practitioner with 46 years experience. He worked for 12 years on the hospital staff of 2 private hospitals in Hong Kong including tenures at each hospital as Chief of Staff.

He undertook postgraduate training in the UK in the field of paediatrics and worked there for a short period. Further training in various fields was undertaken in HK, USA and Australia. He held a teaching position in a tertiary institution in Australia in 1984.


Interests to date have included Nutritional and Environmental Medicine, Child Health and Family Medicine. More recently his interests have expanded to include Photobiomodulation, surgical allografts and Lifestyle Medicine. He recently sold his general practice to concentrate on other interests including an advisory role to Surgical Biofix.

Want more information?